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Abstract
Astrocytes express a large variety of G protein-coupled receptors (GPCRs) which mediate
the transduction of extracellular signals into intracellular calcium responses. This transduc-
tion is provided by a complex network of biochemical reactions which mobilizes a wealth
of possible calcium-mobilizing second messenger molecules. Inositol 1,4,5-trisphosphate is
probably the best known of these molecules whose enzymes for its production and degra-
dation are nonetheless calcium-dependent. We present a biophysical modeling approach
based on the assumption of Michaelis-Menten enzyme kinetics, to effectively describe GPCR-
mediated astrocytic calcium signals. Our model is then used to study different mechanisms
at play in stimulus encoding by shape and frequency of calcium oscillations in astrocytes.
1 Introduction
Calcium signaling is the most common measured readout of astrocyte activity in response to
stimulation, be it by synaptic activity, by neuromodulators diffusing in the extracellular milieu,
or by exogenous chemical, mechanical or optical stimuli. In this perspective, the individual
astrocytic Ca2+ transient is thought, to some extent, as an integration of the triggering stimulus
(Perea and Araque, 005a), and is thus regarded as an encoding or decoding of this stimulus,
depending on the point of view (Carmignoto, 2000; De Pitta` et al., 2013).
Multiple and varied are the spatiotemporal patterns of Ca2+ elevations recorded from as-
trocytes in response to stimulation, each possibly carrying its own encoding (Bindocci et al.,
2017). Insofar as different encoding modes could correspond to different downstream signal-
ing, including gliotransmission and thereby regulation of synaptic function, understanding the
biophysical mechanisms underlying rich Ca2+ dynamics in astrocytes is crucial.
Calcium-induced Ca2+ release (CICR) from the endoplasmic reticulum (ER) is arguably
the best characterized mechanism of Ca2+ signaling in astrocytes (Zorec et al., 2012). It en-
sues from nonlinear properties of Ca2+ channels which are found on the ER membrane and
are gated by the combined action of cytosolic Ca2+ and the second messenger molecule inositol
1,4,5-trisphosphate (IP3) (Shinohara et al., 2011, see also Chapters 2–4). This second messen-
ger molecule can be produced by the astrocyte either spontaneously or, notably, in response
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to activation by extracellular insults activation of G protein-coupled receptors (GPCRs) found
on the cell’s plasma membrane (Parri and Crunelli, 2003; Panatier et al., 2011; Volterra et al.,
2014). Hence, IP3 together with these receptors, can be regarded as integral components
of the interface whereby an astrocyte transduces extracellular insults into Ca2+ responses
(Marinissen and Gutkind, 2001). Characterizing this interface is thus an essential step in our
understanding of the emerging complexity of Ca2+ signals, and we devote this chapter to this
purpose. In the first part of the chapter, we will present a concise framework to model in-
tracellular IP3 signaling in astrocytes. This framework is general and can easily be extended
to include additional biological details, such as for example, the regulation of GPCR binding
efficiency by protein kinase C. Some of the models presented in this chapter are also subjected
to revision and comparison with other astrocyte models in Chapters 16 and 18.
2 Modeling intracellular IP3 dynamics
2.1 Agonist-mediated IP3 production
G protein-coupled receptors form a large family of receptors which owe their name to their
extensively studied interaction with heterotrimeric G proteins (composed of an α, β and γ sub-
unit) which undergo conformational changes that lead to the exchange of GDP for GTP, bound
to the α-subunit, following receptor activation. Consequently, the Gα- and Gβγ-subunits stim-
ulate enzymes thereby activating or inhibiting the production of a variety of second messengers
(Marinissen and Gutkind, 2001).
Among all GPCRs, those that contain the Gαq subunit are linked with the cascade of chem-
ical reactions that leads to IP3 synthesis. There, the Gαq subunit promotes activation of the
enzyme pospholipase Cβ (PLCβ) which hydrolizes the plasma membrane lipid phosphatidyli-
nositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and IP3 (Rebecchi and Pentyala,
2000). Examples of such receptors expressed by astrocytes ex vivo and in vivo are the type I
metabotropic glutamate receptor 1 and 5 (mGluR1/5) (Wang et al., 2006; Sun et al., 2013), the
purinergic receptor P2Y1 (Jourdain et al., 2007; Di Castro et al., 2011; Sun et al., 2013), the
muscarinic receptor mAchR1α (Takata et al., 2011; Chen et al., 2012; Navarrete et al., 2012)
and the adrenergic α1 receptor (Bekar et al., 2008; Ding et al., 2013). While these receptors
bind different agonists, and likely display receptor-specific binding kinetics, they all share the
same downstream signaling pathway and therefore may be modeled in a similar fashion.
Several are the available models for Gαq-containing receptors, and the choice of what model
to use rather than another depends on the level of biological detail and the questions one is
interested in. Here our focus is on the rate of IP3 production upon activation of these receptors,
so we wish to keep as simple as possible the description of the reactions that regulate the
activation of PLCβ by αq, β and γ subunits. This is possible, assuming that these reactions
are much faster than the downstream ones that result in IP3 production. In this case, a quasi
steady-state approximation (QSSA) holds whereby, in the series of reactions that leads from
receptor agonist binding to activation of PLCβ, the intermediate reactions involving the three
receptor’s subunits are at equilibrium on the time scale of the production of activated PLCβ.
Accordingly, assuming that on average the receptor at rest (R) requires nmolecules of an agonist
(A) to promote activation of PLCβ (R*) at rate ON , we can write
R + nA
ON R∗ (1)
We further make another assumption: that the cascade of reactions that leads to GPCR-
mediated IP3 synthesis has a Michaelis-Menten kinetics (see Appendix A.2), so the IP3 pro-
duction by PLCβ (Jβ) can be taken proportional to the fraction of bound receptors, defined
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as ΓA = [R
∗]/[R]T, with [R]T –– [R] + [R*] being the total receptor concentration at the site of
IP3 production, i.e.,
Jβ = Oβ · ΓA (2)
In the above equation Oβ is the maximal rate of IP3 production by PLCβ and lumps informa-
tion on receptor surface density as well as on the size of the PIP2 reservoir. Importantly, these
two quantities may not be fixed, insofar as receptors are subjected to desensitization, inter-
nalization and recycling, and the reservoir of PIP2 could also be modulated by cytosolic Ca
2+
and IP3 (Rhee and Bae, 1997). The reader interested in modeling these aspects may refer to
Lemon et al. (2003). In the following, we will assume Oβ constant for simplicity.
To seek an expression for Jβ, termination of PLCβ signaling has to be considered. With this
regard, as illustrated in Figure 1A, there are two possible pathways whereby IP3 production by
PLCβ ends (Rebecchi and Pentyala, 2000). One is by reconstitution of the inactive G protein
heterotrimer, and coincides with unbinding of the agonist from the receptor, due to the intrinsic
GTPase activity of the activated Gαq subunit. The other is by phosphorylation of the receptor,
the Gαq subunit, PLCβ or some combination thereof by conventional protein kinases C (cPKC)
(Ryu et al., 1990; Codazzi et al., 2001). This phosphorylation modulates either receptor affinity
for agonist binding, or coupling of the bound receptor with the G protein, or coupling of the
activated G protein with PLCβ, ultimately resulting in receptor desensitization (Fisher, 1995).
Denoting by cPKC* the active, receptor-phosphorylating kinase C, termination of PLCβ-
mediated IP3 production can then be modeled by the following pair of chemical reactions:
R∗
ΩN R+ nA (3)
cPKC∗ +R∗
OKR
ΩKR
cPKC∗−R∗ ΩK cPKC∗ +R+ nA (4)
From equations 3–4 we have:
dR∗
dt
= ON [A]
n[R]− ΩN [R∗]−OKR[cPKC∗][R∗] + ΩKR[cPKC∗−R∗] (5)
d[cPKC∗−R∗]
dt
= OKR[cPKC
∗][R∗]− (ΩKR +ΩK)[cPKC∗−R∗] (6)
Assuming that production of the intermediate kinase-receptor complex is at quasi steady state
in reaction 4, i.e. d[cPKC∗−R∗]/dt ≈ 0, provides (equation ??)
[cPKC∗−R∗] = OKR
ΩKR +ΩK
[cPKC∗][R∗] (7)
Then, substituting this latter equation in equation 5 gives
dR∗
dt
= ON [A]
n[R]− ΩN [R∗]−OKR
(
1− ΩKR
ΩKR +ΩK
)
[cPKC∗][R∗]
= ON [A]
n[R]− ΩN [R∗]−OK [cPKC∗][R∗] (8)
where we defined OK = OKR (1− ΩKR/ (ΩKR +ΩK)).
To retrieve an equation for [cPKC*], we consider the fact that activation of cPKC requires
binding to the kinase of free cytosolic Ca2+ (C) and DAG, but only if Ca2+ binds first, cPKC can
get sensibly activated by DAG (Oancea and Meyer, 1998). Accordingly, the following sequential
binding reaction scheme for cPKC activation may be assumed:
cPKC + Ca2+
OKC
ΩKC
cPKC ′ (9)
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cPKC ′ +DAG
OKD
ΩKD
cPKC∗ (10)
where cPKC is the inactive kinase, and cPKC ′ denotes the Ca2+-bound kinase complex.
By QSSA in reaction 4 it follows that the available activated kinase approximately equals
to [cPKC*]T = [cPKC*] + [cPKC* –R*]≈ [cPKC*]. Moreover, it can be assumed that only
a small fraction of cPKC ′ is bound by DAG so that [cPKC∗] ≪ [cPKC ′]. In this fashion,
the available cPKC, denoted by [cPKC]T, can be approximated by [PKC]T≈ [PKC] + [PKC ′].
Accordingly, solving reactions 9 and 10 for [PKC∗] provides
[cPKC∗] =
(
[cPKC∗] + [cPKC ′]
) · H1 ([DAG],KKD)
≈ [cPKC ′] · H1 ([DAG],KKD)
= [cPKC]T · H1 (C,KKC) · H1 ([DAG],KKD) (11)
where KKD = ΩKD/OKD and KKC = ΩKC/OKC , and H1 (x,K) denotes the Hill function
x/(x +K) (Appendix A.1). In practice the activation of the kinase consists of two sequential
translocations to the plasma membrane of its C2 and C12 domains (Oancea and Meyer, 1998).
The translocation of C2 is regulated by Ca2+ whereas that of C12 is by DAG. In this process
however, experiments showed that the initial translocation of C2 is the rate limiting step for
kinase activation (Shinomura et al., 1991), inasmuch as C12 translocation rapidly follows that
of C2 (Codazzi et al., 2001). This agrees with the notion that the cPKC affinity for DAG
is regarded to be much higher than the affinity of the kinase for Ca2+, i.e. KKD ≪ KKC
(Nishizuka, 1995). Since the product of two Hill functions with widely separated constants
can be approximated by the Hill function with the largest constant (De Pitta` et al., 2009),
equation 11 can be rewritten as
[cPKC∗] ≈ [cPKC]T · H1 (C,KKC) (12)
which, once replaced in equation 8, gives:
d[R∗]
dt
= ON [A]
n[R]− ΩN
(
1 +
OK [cPKC]T
ΩN
H1 (C,KKC)
)
[R∗] (13)
Finally, dividing both left and right terms in the above equation by [R]T, equation 13 can be
rewritten as
dΓA
dt
= ON [A]
n (1− ΓA)− ΩN (1 + ζ · H1 (C,KKC)) ΓA (14)
where ζ = OKC [cPKC]T/ΩN quantifies the maximal receptor desensitization by cPKC. In the
approximation that receptor binding and activation is much faster than the effective PLCβ-
mediated IP3 production, ΓA can be solved for the steady state. In this fashion, IP3 production
by PLCβ in equation 2 becomes
Jβ = Oβ · Hn
(
[A], (KN (1 + ζH1 (C,KKC)))
1
n
)
(15)
where KN = ΩN/ON . The Hill coefficient n denotes cooperativity of the binding reaction of
the agonist with the receptor and is both receptor and agonist specific. For example, glutamate
binding to subtype 1 mGluRs, such as those expressed by astrocytes (Gallo and Ghiani, 2000),
is characterized by negative cooperativity and found in association with a Hill coefficient of
n = 0.48−0.88 (Suzuki et al., 2004). On the contrary, binding of ATP to P2Y1Rs of dorsal spinal
cord astrocytes from rats is characterized instead by almost no cooperativity and n = 0.9 − 1
(Fam et al., 2000).
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2.2 IP3 production by receptors with α subunits other than q-type
A series of other astrocytic GPCRs, that traditionally associate with non-αq subunits, have also
been reported to mediate IP3-triggered CICR, both in situ and in vivo. These include Gαi/o-
coupled GABAB receptors (Kang et al., 1998; Serrano et al., 2006; Mariotti et al., 2016), endo-
cannabinoid CB1 receptors (Navarrete and Araque, 2008; Min and Nevian, 2012), adenosiner-
gic A1 receptors (Cristo´va˜o-Ferreira et al., 2013), adrenergic α2 receptors (Bekar et al., 2008),
and dopaminergic D2/3 receptors (Jennings et al., 2017); as well as Gαs-coupled receptors
like adenosine A2A receptors (Cristo´va˜o-Ferreira et al., 2013), and dopamine D1/5 receptors
(Jennings et al., 2017). αi/o and αs subunits are not expected to be linked with IP3 synthe-
sis (Marinissen and Gutkind, 2001), rather they respectively inhibit or stimulate intracellular
production of cAMP. Therefore the mechanism whereby these receptors could also promote
mobilization of Ca2+ from IP3-sensitive ER stores remains a matter of investigation.
One obvious possibility is that some of these receptors could be atypical in astrocytes and also
be coupled with Gαq, as it seems the case for example of astrocytic CB1Rs in the hippocampus
(Navarrete and Araque, 2008) and in the basal ganglia (Mart´ın et al., 2015). Biased agonism
could also be another possibility since the spatiotemporal pattern of agonist action on GPCRs
could be quite different depending on agonist-binding kinetics of the receptor, especially if
agonists differentially engage dynamic signalling and regulatory processes (Overington et al.,
2006), such as in the likely scenario of synapse-astrocyte interactions (Heller and Rusakov,
2015). However, there is not yet direct structural evidence for distinct receptor conformations
linked to specific signals such as distinct G protein classes, and future studies are required
to compare crystal structures of astrocytic GPCRs bound to biased and unbiased ligands to
establish these relationships (Violin et al., 2014).
Alternatively, other signaling pathways mediated by cAMP that result in CICR could also
be envisaged. In particular, Doengi et al. (2009) reported that GABA-evoked astrocytic Ca2+
events in the olfactory bulb are fully prevented by blockers of astrocytic GABA transporters
(GATs), but only partially by GABAB antagonists. GAT activation leads to an increase of
intracellular Na+, since this ion is cotransported with GABA, and such increase indirectly
inhibits the Na+/Ca2+ exchanger on the plasma membrane. In turn, the ensuing Ca2+ increase
could be sufficient to induce Ca2+ release from internal stores by stimulation of endogenous IP3
production (Losi et al., 2014, see the following Section). This possibility is further corroborated
by the observation that astrocytic GATs could indeed be inhibited or stimulated respectively
by A1Rs or A2ARs (Cristo´va˜o-Ferreira et al., 2013).
Yet other mechanisms could be at play for different receptors. Dopaminergic receptors for
example could either increase (D1/5 receptors) or decrease (D2/3 receptors) intracellular Ca
2+
levels in astrocytes (Jennings et al., 2017). This could indeed be explained assuming a possible
action of these receptors on GATs which, similarly to adenosinergic receptors, could respectively
increase or reduce GABA/Na+ cotransport into the cell, ultimately promoting or inhibiting
CICR according to what was suggested for GABABRs. However there is also evidence that
nontoxic levels of dopamine could be metabolized by monoamine-oxidase in cultured astrocytes,
resulting in the production of hydrogen peroxide (Vaarmann et al., 2010). This reactive oxygen
species ultimately activates lipid peroxidation in the neighboring membranes which in turn
triggers PLC-mediated IP3 production and CICR. Overall these different scenarios unravel
additional complexity in the possible mechanisms of GPCR-mediated CICR in astrocytes and
call for future modeling efforts that are beyond the scope of this chapter.
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2.3 Endogenous IP3 production
Phospholipase Cδ (PLCδ) is the enzyme responsible of endogenous IP3 production in as-
trocytes, that is IP3 production that does not require external (i.e. exogenous) stimulation
(Ochocka and Pawelczyk, 2003; Suh et al., 2008). The specific catalytic activity of this enzyme
in the presence of cytosolic Ca2+ is 50- to 100-fold greater than Ca2+-stimulated activity of
PLCβ in the absence of activating G protein subunits (Rebecchi and Pentyala, 2000), suggest-
ing that PLCδ is prominently activated by increases of intracellular Ca2+ (Rhee and Bae, 1997).
Figure 1B exemplifies the biochemical network associated with PLCδ activation. Structural
and mutational studies of PLCδ complexes with Ca2+ and IP3, revealed complex interactions
of Ca2+ with several negatively charged residues within the PLCδ catalytic domain (Essen et al.,
1996, 1997; Rhee and Bae, 1997), hinting cooperative binding of at least two Ca2+ ions with this
enzyme (Essen et al., 1997). In agreement with these experimental findings, we model PLCδ-
mediated IP3 production (Jδ) as (Pawelczyk and Matecki, 1997; Ho¨fer et al., 2002):
Jδ = Jˆδ(I) · H2 (C,Kδ) (16)
where H2 (C,Kδ) denotes the Hill function of C with coefficient 2 and affinity Kδ (Appendix B),
and Jˆδ(I) is the maximal rate of IP3 production by PLCδ which depends on intracellular IP3
(I). Experiments revealed that high IP3 concentrations, i.e. > 1 µm, inhibit PLCδ activity
by competing with PIP2 binding to the enzyme (Allen and Barres, 2009). Accordingly, the
maximal PLCδdependent IP3 production rate can be modeled by
Jˆδ(I) =
Oδ
1 + Iκδ
= Oδ (1−H1 (I, κδ)) (17)
where Oδ is the maximal rate of IP3 production by PLCδ and κδ is the inhibition constant
of PLCδ activity.
2.4 IP3 degradation
There are two pathways for IP3 degradation in astrocytes. The first one is by dephosphorylation
of IP3 by inositol polyphosphate 5-phosphatase (IP-5P). The other one occurs through phos-
phorylation of IP3 by the IP3 3-kinase (IP33K). Both pathways could be Ca
2+ dependent but
in opposite ways: while the activity of IP33K is stimulated by cytosolic Ca
2+ (Communi et al.,
1997), IP-5P is inhibited instead (Communi et al., 2001) (Figure 2A). Thus, depending on
the Ca2+ concentration in the cytoplasm, different mechanisms of IP3 degradation could ex-
ist (Sims and Allbritton, 1998). Moreover, IP-5P-mediated IP3 degradation could also be in-
hibited by competitive binding of inositol 1,3,4,5-tetrakisphosphate (IP4) produced by IP3-
3K-mediated IP3 phosphorylation (Connolly et al., 1987; Erneux et al., 1998), thereby making
the two degradation pathways interdependent (Hermosura et al., 2000). However, we will not
consider this aspect any further, since modeling of this reaction pathway requires a detailed
consideration of the complex metabolic network underpinning degradation of the large family
of inositol phosphates (Communi et al., 2001; Irvine and Schell, 2001). The reader interested
in these aspects may refer to Dupont and Erneux (1997) for a sample modeling approach to the
problem.
Both IP-5P-mediated dephosphorylation (J5P ) and IP33K-mediated phosphorylation of IP3
(J3K) can be described by Michaelis-Menten kinetics (Irvine et al., 1986; Togashi et al., 1997),
i.e.,
J5P = Jˆ5P · H1 (I,K5) (18)
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J3K = Jˆ3K(C) · H1 (I,K3) (19)
Since K5P > 10 µm (Verjans et al., 1992; Sims and Allbritton, 1998), and such high IP3 con-
centrations are unlikely to be physiological (Lemon et al., 2003; Kang and Othmer, 2009), the
activity of IP-5P can be assumed far from saturation. Accordingly, the IP3 degradation rate
by IP-5P can be linearly approximated by (Stryer, 1999):
J5P ≈ Ω5P · I (20)
where Ω5P = Jˆ5P /K5 is the maximal rate of IP-5P-mediated IP3 degradation in the linear
approximation.
IP3 phosphorylation by IP33K is regulated in a complex fashion (Figure 2A). For resting con-
ditions, when intracellular IP3 and Ca
2+ concentrations are below 0.1 µM, (Parpura and Haydon,
2000; Mishra and Bhalla, 2002; Kang and Othmer, 2009), it is very slow. On the other hand,
as Ca2+ increases, IP33K activity is substantially stimulated by its phosphorylation by CaMKII
in a Ca2+/calmodulin (CaM)–dependent fashion (Communi et al., 1997). A further possibil-
ity could eventually be that IP33K is also inhibited by Ca
2+-dependent PKC phosphorylation
(Sim et al., 1990), however, since evidence for the existence of such inhibitory pathway is con-
tradictory (Communi et al., 1995), this possibility will not be taken into further consideration
in this study.
Phosphorylation of IP33K by active CaMKII (i.e. CaMKII*) only occurs at a single threonine
residue (Communi et al., 1997, 1999), so that it can be assumed that the rate of IP33K phos-
phorylation is J∗3K(C) ∝ [CaMKII∗]. On the other hand, activation of CaMKII is Ca2+/CaM-
dependent and occurs in a complex fashion because of the unique structure of this kinase, which
is composed of ∼12 subunits, with three to four phosphorylation sites each (Kolodziej et al.,
2000). Briefly, Ca2+ increases lead to the formation of a Ca2+ –CaM complex (CaM+) that may
induce phosphorylation of some of the sites of each CaMKII subunit. However, only when two
of these sites at neighboring subunits are phosphorylated, CaMKII quickly and fully activates
(Hanson et al., 1994). Despite the multiple CaM+ binding reactions in the inactive kinase,
experiments showed that KII activation by CaM+ can be approximated by a Hill equation
with unitary coefficient (De Konick and Schulman, 1998). Hence, the following kinetic reaction
scheme for CaMKII phosphorylation can be assumed:
4Ca2+ +CaM
O0
Ω0
CaM+ (21)
KII + CaM+
Ob
Ωb
CaMKII
Ωa
Ωi
CaMKII∗ (22)
Consider then first the binding reaction in 22. Assuming that the second step is very rapid with
respect to the first one (Thiel et al., 1988; De Konick and Schulman, 1998), the generation
of CaMKII* is in equilibrium with CaMKII consumption, i.e.,
[CaMKII∗] ≈ Ωa
Ωi
[CaMKII] (23)
Then, under the hypothesis of quasi-steady state for CaMKII,
d[CaMKII]
dt
= Ob [KII][CaM
+]− (Ωa +Ωb) [CaMKII] + Ωi [CaMKII∗] ≈ 0 (24)
Replacing [CaMKII∗] from equation 23 in the latter equation provides
[CaMKII∗] = KaKb[KII][CaM
+] (25)
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where Ka = Ωa/Ωi and Kb = Ob/Ωb. Defining the total kinase II concentration as
[KII]T = [KII]+ [CaMKII]+ [CaMKII*] and assuming it constant, equation 25 can be rewritten
as
[CaMKII∗] =
Ka[KII]T
1 +Ka
· H1
(
[CaM+],Km
)
(26)
with Km = (Kb (1 +Ka))
−1.
The substrate concentration for the enzyme-catalyzed reaction 22 is provided by reaction 21
and reads (by QSSA)
[CaM+] = [CaM] · H4 (C,K0) (27)
with K0 = O0/Ω0. Therefore, replacing the latter expression for [CaM
+] in equation 26, finally
provides
[CaMKII∗] =
Ka[KII]T
1 +Ka
(
1 +
Km
[CaM]
)−1
· H4
(
C,
K0Km
Km + [CaM]
)
(28)
Defining the Ca2+ affinity constant of IP33K as KD = K0Km/ (Km + [CaM]), the above cal-
culations show that, despite its complexity, the reaction cascade underlying the activation
of CaMKII can be concisely described by a Hill function of the Ca2+ concentration (C) so
that [CaMKII∗] ∝ H4 (C,KD). Accordingly, it is also Jˆ3K(C) ∝ H4 (C,KD), and equation 19
for IP33K-mediated IP3 degradation can be rewritten as
J3K = O3K · H4 (C,KD)H1 (I,K3) (29)
where O3K is the maximal rate of IP3 degradation by IP33K.
3 Encoding of stimulation by combined IP3 and Ca
2+ dynamics
3.1 The G-ChI model for IP3/Ca
2+ signaling
A corollary of the biological and modeling arguments exposed in the previous section is that
Ca2+ and IP3 signals are, generally speaking, dynamically coupled in astrocytes. This implies
that a complete model that mimics astrocytic IP3 signaling must also include a description
of CICR. An example of such models is the so-called ChI model originally introduced by
De Pitta` et al. (2009), which is constituted by three ODEs respectively for intracellular Ca2+
(C), the IP3R gating variable h and the mass-balance equation for intracellular IP3 lumping
terms, (16), (20) and (29), i.e.
dC
dt
= Jr(C, h, I) + Jl(C)− Jp(C) (30)
dh
dt
= Ωh(C, I) (h∞(C, I) − h) (31)
dI
dt
= OδH2 (C,Kδ) (1−H1 (I, κδ))−O3K H4 (C,KD)H1 (I,K3)− Ω5P I (32)
The above model can be extended to explicitly modeling of GPCR dynamics by a G-ChI model.
To this aim, we add to the right-hand side of equation 32 the contribution of GPCR-mediated
IP3 synthesis given by equation 15. However, if one is interested in how GPCR kinetics evolves
with IP3 and Ca
2+ dynamics, then the formula for Jβ given by equation 2 must be used instead
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of equation 15. Accordingly, the above system of equations must be completed by equation 14
for astrocytic receptor activation, i.e.
dΓA
dt
= . . . (14)
dC
dt
= . . . (30)
dh
dt
= . . . (31)
dI
dt
= OβΓA +OδH2 (C,Kδ) (1−H1 (I, κδ))−O3K H4 (C,KD)H1 (I,K3)− Ω5P I (33)
Regarding the differential equations for the variables C and h above, the original formulation
of the G-ChI model considered the Li-Rinzel description for CICR previously introduced in
Chapter 3 (Li and Rinzel, 1994). In the following, we will refer to this formulation. In practice
however, it must be noted that any suitable model of Ca2+ and IP3R dynamics discussed in
Chapters 2, 3 and 16 can be adopted in lieu of the Li-Rinzel description, and accordingly
different models of G-ChI type may be developed, each possibly customized to study specific
aspects of coupled IP3 and Ca
2+ signaling in astrocytes.
Figure 3 illustrates some characteristics of IP3 and Ca
2+ dynamics reproduced by the G-
ChI model. In the left panel of this figure, IP3R kinetic parameters are chosen to fit, as closely
as possible, experimental data points for the steady-state open probabilities of type-2 IP3Rs at
fixed Ca2+ (solid line) and IP3 concentrations (dashed line). In the right panel, the remainder
of the parameters of the model are then set to reproduce (solid black line) a sample Ca2+ trace
imaged by confocal microscopy on cultured astrocytes (gray data points). It may be observed
how the associated IP3 and h oscillations predicted by the model, are almost out of phase with
respect to the Ca2+ ones. For h, this is due to IP3R kinetics, whereby an increase of cytosolic
Ca2+ promotes receptor inactivation. For IP3 instead, this dynamics is a direct consequence of
the Ca2+-dependent rate of degradation of this molecule by the IP33K enzyme. This is a crucial
aspect of intracellular IP3 regulation in astrocytes which is addressed more in detail below.
3.2 Different regimes of IP3 signaling
To develop the G-ChI model in Section 2, we stressed on the molecular details of the Ca2+
dependence of the different enzymes involved in IP3 signaling, yet how this dependence shapes
Ca2+ and IP3 oscillations remains to be elucidated. With this purpose, we consider in Figure 4
the simple scenario of Ca2+ oscillations triggered by repetitive stimulation of an astrocyte by
puffs of extracellular glutamate (top three panels), and look at the different contributions to IP3
production and degradation underpinning the ensuing Ca2+ and IP3 dynamics (lower panels).
With this regard, it may be noted how the total rate of IP3 production (dashed line in the
fourth panel from top) almost resembles the dynamics of activation of astrocyte receptors (ΓA,
second panel from top) except for little bumps in correspondence of Ca2+ pulse-like elevations
(solid trace, third panel from top). Consideration of the different contributions to IP3 by PLCβ
(orange trace) and PLCδ (blue trace) reveals that, while most of IP3 production is driven by
mGluR-mediated PLCβ activation, those bumps are instead caused by PLCδ, whose activation
is substantially boosted during intracellular Ca2+ elevations.
Similar arguments also hold for IP3 degradation (bottom panel). In this case, the total rate
of IP3 degradation (dashed line) closely mimics IP3 dynamics in between Ca
2+ elevations (green
trace, third panel from top), and is mostly contributed by Ca2+-independent IP-5P-mediated
degradation (violet trace). This scenario however changes during Ca2+ elevations, when IP33K
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activation becomes significant and promotes faster rates of IP3 degradation, as mirrored by the
dashed line which peaks in correspondence of Ca2+ oscillations.
Overall, these observations suggest that Ca2+-independent activity of PLCβ and IP-5P vs.
Ca2+-dependent activation of PLCδ and IP33K account for different regimes of IP3 signaling.
One regime corresponds to low intracellular Ca2+ close to resting concentrations, whereby IP3
is mainly produced by receptor-mediated activation of PLCβ against degradation by IP-5P.
The other regime significantly adds to the former for sufficiently high Ca2+ elevations, where
IP3 production is boosted by PLCδ, but also IP3 degradation is faster by IP33K activation.
The contribution to IP3 production and degradation by each enzyme clearly depends on
their intracellular expression as reflected by the values of the rate constants Oβ , Oδ, O3K and
Ω5P in equation 33. Nonetheless, it should be noted that the existence of different regimes of
IP3 production and degradation is regardless of these rate values, insofar as it is set by the
values of the Michaelis-Menten constants of the underpinning reactions, mostly Kδ and KD.
Remarkably, estimates of these two constants are in the range of 0.1 − 1.0 µm, that is well
within the range of Ca2+ elevations expected for an astrocyte, whose average resting Ca2+
concentration is reported to be < 0.15 µm (Zheng et al., 2015). This assures that activation of
PLCδ and IP33K is effective only when intracellular Ca
2+ approaches to, or increases beyond
Kδ and KD, as expected by the occurrence of CICR.
3.3 Signal integration
The existence of different regimes of IP3 signaling shapes the time evolution of IP3 with respect
to stimulation in a peculiar fashion. From Figure 4 (third panel), it may indeed be noted
that, starting from resting values, IP3 increases for each glutamate puff almost stepwise, till it
reaches a peak (or threshold) concentration (normalized to ∼ 1) that triggers CICR, thereby
triggering a Ca2+ pulse-like elevation. This Ca2+ elevation promotes IP3 degradation to some
concentration between its peak and baseline values, in a sort of reset mechanism, leaving IP3
to increase back again to the CICR threshold until the next elevation. In between each Ca2+
elevation, counting from the first one ending at t ≈ 4 s, we may appreciate how IP3 increases
almost proportionally to the number of glutamate puffs, akin to an integrator of the stimulus.
This may readily be proved by analytical arguments approximating, for simplicity, each
glutamate puff occurring at tk by a Dirac’s delta δ(t−tk), so that the external stimulus impinging
on the astrocyte is modeled by Y (t) = G ·∆∑k δ(t− tk), where G ·∆ represents the glutamate
concentration delivered in the time unit per puff (i.e. its dimensions are µm · s). Then, assuming
that in between oscillations, intracellular Ca2+ concentration is close to basal levels, i.e. C ≈ C0,
with C0 < (≪)KKC , Kδ, K3 and h ≈ h∞, it is possible to reduce equations 14 and 33 to
dΓA
dt
≈ −(ONY (t) + ΩN )ΓA +ONY (t) (34)
dI
dt
≈ −J5P + Jβ = −Ω5P I +OβΓA (35)
Using the fact that for puffs delivered at rate ν the identity
∫ t ′′
t ′
∑
k δ(t − tk)dt = ν(t ′′ − t ′)
holds, we can solve equation 34 for ΓA obtaining
ΓA(t) =
∫ t
−∞
ONY (t
′) e−
∫ t
t ′
(ΩN+ONY (t
′′))dt ′′dt ′
=
∫ t
−∞
ONY (t
′) e−ΩN (t−t
′) e−ON
∫ t
t ′
Y (t ′′)dt ′′dt ′
=
∫ t
−∞
ONY (t
′) e−(ΩN+ONG∆ν)(t−t
′)dt ′
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= ONY (t
′) ∗ ZΓA(t) (36)
where “∗” denotes the convolution operator. It is thus apparent that the fraction of acti-
vated receptors ΓA(t) is an integral transform of the stimulus Y (t) by convolution with the
kernel ZΓA(t). Specifically, ZΓA(t) may be regarded as the fraction of astrocyte receptors stim-
ulated by one extracellular glutamate puff – or equivalently, by synaptic release triggered by
an action potential –, and characterizes the encoding of the stimulus by the astrocyte via its
activated receptors.
The IP3 signal resulting from the activated receptors then evolves according to
I(t) =
∫ t
−∞
OβΓA(t
′) e−
∫ t
t ′
Ω5P dt
′′
dt ′ =
∫ t
−∞
OβΓA(t
′) e−Ω5P (t−t
′)dt ′
= OβΓA(t) ∗ ZI(t) (37)
That is the IP3 signal is also an integral transform of the input stimuli through the fraction
of activated receptors ΓA(t), by convolution with the kernel ZI(t) = e
−Ω5P t. In particular,
experimental evidence hints that the rate constant Ω5P is often small compared to the rate of
incoming stimulation (Appendix B), so that ZI(t) ≈ 1. In this case then, equation 37 predicts
that I(t) ≈ ∫ t
−∞
OβΓA(t
′)dt ′, namely that the IP3 signal effectively corresponds to the integral
of the fraction of activated astrocyte receptors.
It is also worth understanding the nature of the threshold concentration that IP3 must reach
in order to trigger CICR. In the G-ChI model, based on the Li-Rinzel description of CICR,
this threshold may be not well-defined and generally varies with the parameter choice as well
as with the shape and amplitude of the delivered stimulation (De Pitta` et al., 2009). Consider
for example Figure 5A where the Ca2+ response of an astrocyte (bottom panel) is simulated
for different color-coded step increases of extracellular glutamate (top panel). It may be noted
that CICR, reflected by one or multiple Ca2+ pulse-like increases, is triggered by glutamate
concentrations greater or equal to the orange trace. However, the IP3 threshold for CICR
(central panel) appears to grow with the extracellular glutamate concentration. This is reflected
by the first ’knee’ of the IP3 curves which reaches progressively higher values of IP3 concentration
as extracellular glutamate increases from orange to lime levels. At the same time, as shown
by the black dashed curve in the top panel of Figure 5B, the latency for emergence of CICR
since stimulus onset (black marks at t = 0) decreases. This can be explained by equations 34
and 35, noting that, while larger glutamate concentrations promote larger receptor-mediated
IP3 production, this increased production is also counteracted by faster degradation by IP-5P,
since this latter linearly increases with IP3. Thus while larger IP3 production assures shorter
delays in the onset of CICR, a larger IP3 level must be reached to compensate for its faster
degradation.
The top panel of Figure 5B further illustrates how the latency period for CICR onset depends
on the activity of the different enzymes regulating IP3 production and degradation. Here the
different colored curves were obtained repeating the simulations of Figure 5A for a 50% increase
of the activity respectively of PLCβ (orange trace), PLCδ (blue trace), IP33K (red trace) and
IP-5P (violet trace). In agreement with our previous analysis, PLCβ and IP-5P have the largest
impact on respectively reducing or increasing the latency period, given that they are the main
enzymes at play in IP3 signaling before CICR onset. The effect of an increase of IP3 production
by PLCδ is instead mainly significant for low glutamate concentrations, such that they could
promote an activation of this enzyme that is comparable to that of PLCβ. Conversely, IP33K
does not have any role in the control of CICR latency since its activation effectively requires
CICR to onset first.
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The variability of IP3 concentrations attained to trigger CICR by different glutamate con-
centrations, and its correlation with the latency for CICR onset, suggest that the mere IP3
concentration is not an effective indicator of the CICR threshold, rather we should consider
instead the total IP3 amount produced in the astrocyte cytosol during the latency period that
precedes CICR onset, that is the integral in time of IP3 concentration during such period. This
is exemplified in the bottom panel of Figure 5B where such integral is plotted as a function of
the different latency values computed in the top panel. It may be appreciated how this integral
is essentially similar for different enzyme expressions (colored curves) yet associated with the
same latency value.
Taken together these results put emphasis on the crucial role exerted by IP3 signaling in the
genesis of agonist-mediated Ca2+ elevations. In particular they suggest that the expression of
different enzymes responsible of IP3 production and degradation, which is likely heterogeneous
across an astrocyte, could locally set different requirements for integration and encoding of
external stimuli by the same cell.
3.4 Role of cPKCs and beyond
Different mechanisms of production and degradation of IP3 are only one example of the possible
many signaling pathways that could shape the nature of Ca2+ signaling in astrocytes. There is
also compelling evidence in vitro that shape and duration of Ca2+ oscillations could be controlled
by astrocyte receptor phosphorylation by cPKCs (Codazzi et al., 2001). To better understand
this aspect of astrocyte Ca2+ signaling, we relax the quasi steady-state approximation on cPKC
phsophorylation and thus rewrite equation 8 as
dΓA
dt
= ON [A]
n (1− ΓA)− (ΩN +OKP ) ΓA (38)
where P denotes the cPKC* concentration at the receptors’ site. This in turn, requires to also
consider a description of cPKC* dynamics, whereby at least two additional equations in the
G-ChI model must be included: one that takes into account P dynamics, but also a further one
that describes DAG dynamics (D), which is responsible for cPKC activation by Ca2+-dependent
translocation of the inactive kinase to the plasma membrane (Oancea and Meyer, 1998).
By QSSA, the quantity of cPKC* is conserved during receptor phosphorylation in reaction 4.
In this fashion, cPKC* production and degradation are only controlled by the pair of reactions 9
and 10. On the other hand, taking into account from Section 2.1 that production of cPKC*
depends on the availability of the Ca2+-bound kinase complex cPKC ′, we may assume at first
approximation that reaction 9 for Ca2+-binding to the kinase is at equilibrium, i.e. [cPKC ′] =
[cPKC]TH1 (C,KKC). Accordingly, we can consider cPKC* dynamics to be driven simply by
reaction 10, i.e.
dP
dt
= JKP − JKD
= OKD[cPKC
′] ·D − ΩKDP
= OKD[cPKC]TH1 (C,KKC) ·D − ΩKDP
≡ OKDH1 (C,KKC) ·D − ΩKDP (39)
where we re-defined OKD ← OKD[cPKC]T as the maximal rate of cPKC* production (in
µms−1).
To model DAG dynamics we start instead from the consideration that PLC isoenzymes
hydrolyze PIP2 into one molecule of IP3 and one of DAG, so that DAG production coincides
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with that of IP3 (Berridge and Irvine, 1989, and see also Figure 2B). Yet, only part of this pro-
duced DAG is used to activate cPKC, while the rest is mainly degraded by diacylglycerol kinases
(DAGKs) into phosphatidic acid (Carrasco and Me´rida, 2007) and, to a minor extent, by diacyl-
glycerol lipases (DAGLs) into 2-arachidonoylglycerol (2-AG), although this latter pathway has
only been linked to some types of metabotropic receptors in astrocytes (Bruner and Murphy,
1990; Giaume et al., 1991; Walter et al., 2004). Other pathways of use of DAG are also possible
in principle, inasmuch as DAG is a key molecule in the cell’s lipid metabolism and a basic
component of membranes. Nonetheless there is evidence that DAG levels are strictly regu-
lated within different subcellular compartments, and DAG generated by GPCR stimulation is
not usually consumed for metabolic purposes (van der Bend et al., 1994; Carrasco and Me´rida,
2007).
DAGK activation reflects the sequence of Ca2+mediated translocation, DAG binding and
activation that is also required for cPKCs, so the two reactions may be thought to be character-
ized by similar kinetics, yet with an important difference. Sequence analysis of DAGKα, γ – the
two isoforms of DAGKs most likely involved in astrocytic GPCR signaling (Dominguez et al.,
2013) – reveals in fact the existence of two EF-hand motifs characteristics of Ca2+-binding and
two C1 domains for DAG binding (Me´rida et al., 2008). In this fashion, a Hill exponent of 2
instead of 1 as in equation 39 must be considered for the DAGK activating reaction, so that
DAGK-mediated DAG degradation can be modeled by
JD = ODH2 (C,KDC)H2 (D,KDD) (40)
Finally, to take into account other mechanisms of DAG degradation (JA), including but not lim-
ited to DAGLs, we assume a linear degradation rate, i.e. JA = ΩDD. This is a crude approxima-
tion insofar as DAGL, could also be activated in a Ca2+-dependent fashion (Rosenberger et al.,
2007). Nonetheless, the complexity of the molecular reactions likely involved in these other
pathways of DAG degradation would require to consider additional equations in our model
which are beyond the scope of this chapter. The reader who is interested in these further as-
pects, may refer to Cui et al. (2016) for a possible modeling approach. For the purposes of our
analysis instead, we will consider the following equation for DAG dynamics:
dD
dt
= Jβ + Jδ − JKP − JD − JA
= OβΓA +OδH2 (C,Kδ) (1−H1 (I, κδ))+
−OKDH1 (C,KKC) ·D −ODH2 (C,KDC)H2 (D,KDD)−ΩDD (41)
Figure 6A shows a comparison of experimental Ca2+ and cPKC* traces with those repro-
duced by the G-ChI model including equations 39 and 41. For inherent limitations of the
Li-Rinzel description of the gating kinetics of IP3Rs, which fails to describe these receptors’
open probability for large Ca2+ concentration (Figure 3) and predicts fast rates of receptor
de-inactivation (O2/d2, Table D1), the G-ChI model cannot generate Ca
2+ peaks as large as
those experimentally observed and shown here. Nonetheless we would like to emphasize how
our model qualitatively matches experimental Ca2+-dependent cPKC* dynamics, accurately
reproducing the phase shift between Ca2+ and cPKC* oscillations. This phase shift is criti-
cally controlled by the constant KKC for Ca
2+ binding to the kinase, along with the rates of
cPKC* production vs. degradation, i.e. OKD vs. ΩKD (equation 39), and the rate of receptor
phosphorylation OK (equation 38).
Figure 6B further reveals the role of these rate constants in the control of Ca2+ oscillations.
In this figure, we simulated the astrocyte response for a step increase of ∼ 1.5 µm extracellular
glutamate, starting from resting conditions, both in the absence of kinase-mediated receptor
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phosphorylation (gray trace) and in the presence of it, for two different OK rate values (black
traces). It may be noted how receptor phosphorylation by cPKC can rescue Ca2+ oscillations
that otherwise would vanish by saturating intracellular IP3 concentrations ensuing from large
receptor activation. This activation indeed is decreased by cPKC* according to equation 38,
thereby regulating intracellular IP3 within the range of Ca
2+ oscillations. Nonetheless, as
the rate of receptor phosphorylation increases (dash-dotted trace), the period of oscillations
appears to slow down and oscillations even fail to emerge, if the supply of cPKC* results in
a phosphorylation rate of astrocyte receptors that exceeds their agonist-mediated activation
(results not shown).
These considerations can be explained considering the period of Ca2+ oscillations as a func-
tion of the extracellular glutamate concentration. As shown in Figure 6C, cPKC-mediated
receptor phosphorylation shifts (black curves) the range of glutamate concentrations that trig-
ger Ca2+ oscillations to higher values than those otherwise expected in the absence of it (gray
curve). In particular, and in agreement with experimental findings (Codazzi et al., 2001), the
exact value of the rate OK for receptor phopshorylation sets the entity of this shift, accounting
either for Ca2+ oscillations of period longer than without receptor phosphorylation, or for the
requirement of larger glutamate concentrations to observe such oscillations. This is respectively
reflected by the portions of the black curves that are within the range of extracellular gluta-
mate concentrations of the gray curve), and those that instead are not. On the other hand,
longer-period oscillations in the presence of receptor phosphorylation are likely to be observed
as long as the rate of cPKC* activation by DAG (OKD) is below some critical value. A three-
fold increase of this rate indeed requires glutamate concentrations beyond those needed in the
absence of receptor phosphorylation to trigger oscillations, regardless of the OK value at play
(blue curves). In this scenario in fact, the large supply of cPKC*, resulting from the high
OKD value, favors phosphorylation of receptors while hindering intracellular buildup of IP3 to
trigger CICR. This in turn requires a larger recruitment of astrocyte receptors by larger agonist
concentrations to evoke Ca2+ oscillations.
4 Conclusions
The modeling arguments introduced in this chapter overall suggest a great richness in the
possible modes whereby astrocytes could translate extracellular stimuli into intracellular Ca2+
dynamics. These modes are brought forth by a complex network of biochemical reactions that
is exquisitely nonlinearly coupled with Ca2+ dynamics through different second messengers,
among which IP3 and possibly DAG could play a paramount signaling role. In particular, the
regulation of different regimes of IP3 production and degradation by Ca
2+ in parallel with the
differential regulation by this latter and DAG of the activities of cPKCs and DAGKs opens to
the scenario of the existence of different regimes of signal transduction that a single astrocyte
could multiplex towards different intracellular targets depending on different local conditions of
neuronal activity.
An interesting implication emerging from our analysis of the regulation of the period of
Ca2+ oscillations by cPKCs and DAG-related lipid signals is the possibility that these pathways,
which could be crucially linked with inflammatory responses underpinning reactive astrocytosis
(Brambilla et al., 1999; Griner and Kazanietz, 2007), could be found at different operational
states, akin to what suggested for proinflammatory cytokines like TNFα (Santello and Volterra,
2012). In our analysis for example, intermediate activation of cPKC activity could promote
Ca2+ oscillations at physiological rates, while an increase of it could exacerbate fast, potentially
inflammatory Ca2+ responses (Sofroniew and Vinters, 2010).
Similar arguments also hold for IP3 signaling. Calcium-dependent IP3 production by PLCδ
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and PLCβ (via cPKC) could modulate the rate of integration of synaptic stimuli and thus dictate
the threshold synaptic activity triggering CICR. On the other hand, the existence of different
regimes of IP3 degradation could be responsible for different cutoff frequencies of synaptic
release, beyond which integration of external stimuli by the cells could cease. In particular, this
cutoff frequency could be mainly set by IP-5P during low synaptic activity, possibly associated
with low intracellular Ca2+ levels, while be dependent on IP33K in regimes of strong astrocyte
Ca2+ activation, and thus ultimately depend on the history of activation of the astrocyte. The
following chapter looks closely at some of these aspects, focusing in particular, on the role of
different IP3 degradation regimes in the genesis and shaping of Ca
2+ oscillations.
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Appendix A Arguments of chemical kinetics
A.1 The Hill equation
In biochemistry, the binding reaction of nmolecules of a ligand L to a receptor macromolecule R,
i.e.,
R + nL
kf
kb
RLn (42)
can be mathematically described by the differential equation
d[RLn]
dt
= kf [R][L]
n − kb[RLn] (43)
where kf , kb denote the forward (binding) and backward (unbinding) reaction rates respectively.
At equilibrium,
0 = kf [R][L]
n − kb[RLn]⇒ [RLn] =
[R][L]n
Kd
(44)
where Kd = kb/kf is the dissociation constant of the binding reaction 42. Then, the fraction
of bound receptor macromolecules with respect to the total receptor macromolecules can be
expressed by the Hill equation (Stryer, 1999)
Bound
Total
=
[RLn]
[R] + [RLn]
=
[L]n
Kd
[L]n
Kd
+ 1
=
[L]n
[L]n +Kd
=
[L]n
[L]n +Kn0.5
= Hn ([L],K0.5) (45)
where the function Hn ([L],K0.5) denotes the sigmoid (Hill) function [L]n / ([L]n + K0.5n), and
K0.5 =
n
√
Kd is the receptor affinity for the ligand L, and corresponds to the ligand concentration
for which half of the receptor macromolecules are bound (i.e. the midpoint of the Hn ([L],K0.5)
curve). The sigmoid shape of Hn ([L],K0.5) denotes saturation kinetics in the binding reac-
tion 42, that is, for [L] ≫ K0.5 almost all the receptor molecules are bound to the ligand, so
that the fraction of bound receptor molecules does not essentially change for an increase of [L].
The coefficient n, also known as Hill coefficient, quantifies the cooperativity among multiple
ligand binding sites. A Hill coefficient n > 1 denotes positively cooperative binding, whereby
once one ligand molecule is bound to the receptor macromolecule, the affinity of the latter for
other ligand molecules increases. Conversely, a value of n < 1 denotes negatively cooperative
binding, namely when binding of one ligand molecule to the receptor decreases the affinity of
the latter to bind further ligand molecules. Finally, a coefficient n = 1 denotes completely
independent binding when the affinity of the receptor to ligand molecules is not affected by its
state of occupation by the latter.
For unimolecular reactions, n = 1 coincides with the number of binding sites of the receptor.
For multimolecular reactions involving η > 1 ligand molecules instead, the Hill coefficient in
general, only loosely estimates the number of binding sites, being n ≤ η (Weiss, 1997). This
follows from the hypothesis of total allostery that is implicit in the reaction 42, whereby the Hill
function is a very simplistic way to model cooperativity. It describes in fact the limit case where
affinity is 0 if no ligand is bound, and infinite as soon as one receptor binds. That is, only two
states are possible: free receptor and receptor with all ligand bound. More realistic descriptions
are available in literature, such as for example the Monod–Wyman–Changeux (MWC) model,
but they yield much more complex equations and more parameters (Changeux and Edelstein,
2005).
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A.2 The Michaelis-Menten model of enzyme kinetics
The Michaelis-Menten model of enzyme kinetics is one of the simplest and best-known models
to describe the kinetics of enzyme-catalyzed chemical reactions. In general enzyme-catalyzed
reactions involve an initial binding reaction of an enzyme E to a substrate S to form a com-
plex ES. The latter is then converted into a product P and the free enzyme by a further reaction
that is mediated by the enzyme itself and can be quite complex and involve several interme-
diate reactions. However, there is typically one rate-determining enzymatic step that allows
this reaction to be modeled as a single catalytic step with an apparent rate constant kcat. The
resulting kinetic scheme thus reads
E + S
kf
kb
ES
kcat P + E (46)
By law of mass action, the above kinetic scheme gives rise to 4 differential equations (Stryer,
1999):
d[S]
dt
= −kf [E][S] + kb[ES] (47a)
d[E]
dt
= −kf [E][S] + kb[ES] + kcat[ES] (47b)
d[ES]
dt
= kf [E][S]− kb[ES]− kcat[ES] (47c)
d[P]
dt
= kcat[ES] (47d)
In the Michaelis-Menten model the enzyme is a catalyst, namely it only facilitates the reac-
tion whereby S is transformed into P, hence its total concentration [E]T –– [E] + [ES] must be
preserved. This is indeed apparent by the sum of the second and the third equations above,
since: d([E]+[ES])dt =
d[E]T
dt = 0⇒ [E]T = const.
The system of equations 47 can be solved for the products P as a function of the concentration
of the substrate [S]. A first solution assumes instantaneous chemical equilibrium between the
substrate S and the complex ES, i.e. d[S]dt = 0, whereby the initial binding reaction can be
equivalently described by a Hill equation (Keener and Sneyd, 2008), i.e.,
[ES]
[E]T
=
[S]
[S] +Kd
⇒ [ES] = [E]T [S]
[S] +Kd
(48)
Alternatively, the quasi-steady-state assumption (QSSA) that [ES] does not change on the time
scale of product formation can be made, so that ddt [ES] = 0 ⇒ kf [E][S] = kb[ES] + kcat[ES]
(Keener and Sneyd, 2008), and
kf [E][S] = kb[ES] + kcat[ES]⇒ kf ([E]T − [ES]) [S] = kb[ES] + kcat[ES]
⇒ kf [E]T [S] = (kf [ES][S] + kb[ES] + kcat[ES])
⇒ [ES] = [E]T
[S]
[S] +KM
(49)
where KM = (kb + kcat) /kf is the Michaelis-Menten constant of the reaction which quantifies
the affinity of the enzyme to bind to the substrate.
Regardless of the hypothesis made to find an expression for [ES], the rate vP of production
of P can be always written as
vP =
d[P]
dt
= kcat[ES] = kcat[E]T
[S]
[S] +K0.5
= vmax
[S]
[S] +K0.5
(50)
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where vmax = kcat[E]T is the maximal rate of production of P in the presence of enzyme satu-
ration, when all the available enzyme takes part in the reaction; and the affinity constant K0.5
equals the dissociation constant Kd of the initial binding reaction in the chemical equilibrium
approximation (equation 48), or the Michaelis-Menten constant in the QSSA (equation 49).
An important corollary of the Michaelis-Menten model of enzyme kinetics is that the fraction
of the total enzyme that forms the intermediate complex ES can be expressed by a Hill equation
of the type
[ES]
[E]T
=
[S]
[S] +K0.5
= H1 ([S],K0.5) (51)
and K0.5 can be regarded as the half-saturating substrate concentration of the reaction. Simi-
larly, the effective reaction rate vP (equation 51) is proportional to the maximal reaction rate
by a Hill-like term H1 ([S],K0.5).
Appendix B Parameter estimation
B.1 Metabotropic receptors
Rate constants ON , ΩN (equation 14) lump information on astrocytic metabotropic receptors’
activation and inactivation, namely how long it takes for these receptors, once bound by the
agonist, to trigger PLCβ-mediated IP3 production and how long this latter lasts. Since IP3
production mediated by agonist binding with the receptors controls the initial intracellular
Ca2+ surge, these two rate constants may be estimated by rise times of agonist-triggered Ca2+
signals. With this regard, experiments reported that application of 50 µm DHPG – a potent
agonist of mGluR5 which are the main type of metabotropic glutamate receptors expressed by
astrocytes (Aronica et al., 2003) –, triggers submembrane Ca2+ signals characterized by a rise
time τr = 0.272 ± 0.095 s. Because mGluR5 affinity (K0.5) for DHPG is ∼ 2µm (Brabet et al.,
1995), that is much smaller than the applied agonist concentration, receptor saturation may be
assumed in those experiments whereby the receptor activation rate by DHPG (ODHPG) can be
expressed as a function of τr (Barbour, 2001), i.e. ODHPG ≈ τr/(50 µm) = 0.055−0.113 µm−1s−1,
so that ΩDHPG = ODHPGK0.5 ≈ 0.11 − 0.22 s−1. Corresponding rate constants for glutamate
may then be estimated assuming similar kinetics, yet with K0.5 = KN = ΩN/ON ≈ 3− 10 µm
(Daggett et al., 1995), that is 1.5–5-fold larger than K0.5 for DHPG. Moreover, since rise times
of Ca2+ signals triggered by non-saturating physiological stimulation are faster than in the
case of DHPG (Panatier et al., 2011), it may be assumed that ON > ODHPG. With this re-
gard, for a choice of ON ≈ 3 × ODHPG = 0.3 µm−1s−1, with KN = 6µm such that ΩN =
(0.3 µm−1s−1)(6 µm) = 1.8 s−1, a peak of extracellular glutamate concentration of 250 µm, de-
livered at t = 0 and exponentially decaying at rate Ωc = 40 s
−1 (Clements et al., 1992), is
consistent with a peak fraction of bound receptors of ∼ 0.75 within ∼ 70ms from stimulation
(equation 14), which is in good agreement with experimental rise times.
B.2 IP3R kinetics
We consider a steady-state receptor open probability in the form of popen(C, I) = H31(I, d1) ·
·H31(C, d5)(1−H1 (C,Q2))3 with Q2 = d2(I + d1)/(I + d3) (see Chapter 3) and choose parame-
ters to fit corresponding experimental data by Ramos-Franco et al. (2000) for (i) different Ca2+
concentrations (Cˆ at a fixed IP3 level of I¯ = 1µm, i.e. pˆ(Cˆ); and (ii) for different IP3 concentra-
tions (Iˆ) at an intracellular Ca2+ concentration of C¯ = 25 nm, i.e. pˆ(Iˆ). To reduce the problem
dimensionality while retaining essential dynamical features of IP3 gating kinetics we set d1 = d3
(Li and Rinzel, 1994). Accordingly, defining the vector parameter xp = (d1, d2, d5, O2), we min-
imize the cost function cp(xp) = (popen(Cˆ, I¯) − pˆ(Cˆ))2 + (popen(C¯, Iˆ) − pˆ(Iˆ))2 by the Artificial
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Bee Colony (ABC) algorithm (Karaboga and Basturk, 2007) considering 2000 evolutions of a
colony of 100 individuals.
Ultrastructural analysis of astrocytes in situ revealed that the probability of ER localiza-
tion in the cytoplasmic space at the soma is between ∼40–70% (Pivneva et al., 2008). This
suggests that the corresponding ratio between ER and cytoplasmic volumes (ρA) is comprised
between ∼0.4–0.7.
To estimate the cell’s total free Ca2+ content CT we make the consideration that the rest-
ing Ca2+ concentration in the cytosol is < 0.15 µm (Zheng et al., 2015) and can be neglected
with respect to the amount of Ca2+ stored in the ER (CER) (Berridge et al., 2003). Hence,
with CER ≥ 10 µm (Golovina and Blaustein, 1997) and a choice of ρA ≥ 0.4, it follows that
CT ≈ ρACER ≥ 4µm. In conditions close to store depletion during oscillations (Camello et al.,
2002), this latter value would also coincide with the peak Ca2+ reached in the cytoplasm, which
is reported between < 5µm and ∼ 20 µm (Csorda`s et al., 1999; Parpura and Haydon, 2000;
Kang and Othmer, 2009; Shigetomi et al., 2010).
In our simulations we set ρA = 0.5 while leaving arbitrary the choice of CT as far as the
resulting Ca2+ oscillations qualitatively resemble the shape of those observed in experiments.
The remaining parameters for CICR, i.e. zc = (ΩC , OP ), were chosen to approximate the num-
ber and period of Ca2+ oscillations observed on average in experiments on cultured astrocytes
that were stimulated by glutamate perfusion. By “on average” we mean that we considered the
average trace resulting from n = 5 different Ca2+ signals generated within the same period of
time and by the same stimulus in identical experimental conditions.
B.3 IP3 signaling
Once set the CICR parameters, individual Ca2+ traces used to obtained the above-mentioned
“average trace” were used to search for zp = (Oβ , Oδ, O3K ,Ω5P ), assuming random initial
conditions. The ensuing parameter values were also used in Figures 4–6 although Oβ, Oδ and
O3K were increased, from case to case, by a factor comprised between 1.2− 2 either to expand
the oscillatory range or to promote CICR emergence (by increasing Oβ , Oδ) or termination (by
larger O3K values).
B.4 cPKC and DAG signaling
Calcium-dependent cPKC-mediated phosphorylation has been documented for astrocytic
mGluRs and P2Y1Rs (Codazzi et al., 2001; Hardy et al., 2005) and results in a reduction of
receptor binding affinity by a factor ζ ≈ 2 − 10 (Hardy et al., 2005), or possibly higher de-
pending on the cell’s expression of cPKCs (Nakahara et al., 1997; Shinohara et al., 2011). Since
experiments showed that cPKC is robustly activated only when Ca2+ increases beyond half of
the peak concentration reached during oscillations (Codazzi et al., 2001) then, considering peak
Ca2+ values of ∼ 1 − 3 µm (Shigetomi et al., 2010) allows estimating Ca2+ affinity of cPKC
in the range of KKC ≤ 0.5 − 1.5 µm which indeed comprises the value of ∼ 700 nm predicted
experimentally (Mosior and Epand, 1994). Of the same order of magnitude also is the Ca2+
affinity reported for DAGK, i.e. KDC ≈ 0.3−0.4 µm (Sakane et al., 1991; Yamada et al., 1997).
Reported values of DAG affinities for cPKC and DAGK may considerably differ. Micellar as-
says of cPKCs activity, suggests values of KKD as low as 4.6–13.3 nm (Ananthanarayanan et al.,
2003), whereas studies on purified DAGK suggest a substrate affinity for this kinase of KDD ≈
60 µm (Kanoh et al., 1983). The differences in experimental setups and the possibility that the
activity of these kinases could be widely regulated by different DAG pools make these estimate
of scarce utility for our model, where the DAG concentration is of the same order of magnitude
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of IP3 one. With this regard we choose to set these affinities to 0.1 µm which corresponded in
our simulations to the average intracellular DAG concentration during Ca2+ oscillations.
The remaining parameters, namely zk = (OKD, OK ,ΩD, OD,ΩD) were arbitrarily chosen
considering two constrains: (i) DAG concentration for damped Ca2+ oscillations must stabilize
to a constant value; and (ii) the down phase of cPKC* oscillations must follow that of Ca2+
ones as suggested by experimental observations by Codazzi et al. (2001).
Appendix C Software
The Python file figures.py used to generate the figures of this chapter can be downloaded
from the online book repository at https://github.com/mdepitta/comp-glia-book. The
software for this chapter is organized in two folders. The data folder contains data to fit the
G-ChI model. WebPlotDigitizer 4.0 (https://automeris.io/WebPlotDigitizer) was used
to extract experimental data by Ramos-Franco et al. (2000, Figures 6 and 7) and Codazzi et al.
(2001, Figure 5). The Jupyter notebook file data_loader.ipynb found in this folder contains
the code to load and clean experimental data used in the simulations.
The code folder contains instead all the routines (including figures.py) used for the simu-
lations of this chapter. The two files astrocyte_models.h and astrocyte_models.cpp contains the
core G-ChI model implementation in C/C++11, while the class Astrocyte in
astrocyte_models.py provides the Python interface to simulate the G-ChI model. The model
was integrated by a variable-coefficient linear multistep Adams method in Nordsieck form which
proved robust to correctly solve stiff problems rising from different parameter choices (Skeel,
1986). Model fitting is provided by gchi_fit.py and relies on the PyGMO 2.6 optimization
package (https://github.com/esa/pagmo2.git).
The library gchi_bifurcation.py provides routines to estimate the period and range of Ca2+
oscillation as in Figures 6. These routines use numerical continuation of the extended G-ChI
model by the Python module PyDSTool 0.92 (Clewley, 2012, https://github.com/robclewley/pydstool).
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Appendix D Model parameters used in simulations
Table D1. Model parameters used in the simulations, unless differently specified in figure
captions.
Symbol Description Value Units
Astrocyte receptors
ΩN Rate of receptor de-activation 1.8 s
−1
ON Rate of agonist-mediated receptor activation 0.3 µm
−1s−1
n Agonist binding cooperativity 1 –
IP3R kinetics
d1 IP3 binding affinity 0.1 µm
O2 Inactivating Ca
2+ binding rate 0.325 µm−1s−1
d2 Inactivating Ca
2+ binding affinity 4.5 µm
d3 IP3 binding affinity (with Ca
2+ inactivation) 0.1 µm
d5 Activating Ca
2+ binding affinity 0.05 µm
Ca2+fluxes
CT Total ER Ca
2+ content 5 µm
ρA ER-to-cytoplasm volume ratio 0.5 –
ΩC Maximal Ca
2+ release rate by IP3Rs 7.759 s
−1
ΩL Ca
2+ leak rate 0.1 s−1
OP Maximal Ca
2+ uptake rate 5.499 µms−1
KP Ca
2+ affinity of SERCA pumps 0.1 µm
IP3 production
Oβ Maximal rate of IP3 production by PLCβ 0.8 µms
−1
Oδ Maximal rate of IP3 production by PLCδ 0.025 µms
−1
Kδ Ca
2+ affinity of PLCδ 0.5 µm
κδ Inhibiting IP3 affinity of PLCδ 1.0 µm
IP3 degradation
Ω5P Rate of IP3 degradation by IP-5P 0.86 s
−1
O3K Maximal rate of IP3 degradation by IP33K 0.86 µms
−1
KD Ca
2+ affinity of IP33K 0.5 µm
K3K IP3 affinity of IP33K 1.0 µm
DAG dynamics
ΩD Unspecific rate of degradation 0.26 s
−1
OD Rate of degradation by DAGK 0.45 µms
−1
KDC DAGK affinity for Ca
2+ 0.3 µm
KDD DAGK affinity for DAG 0.1 µm
cPKC signaling
OKD Rate of cPKC* production 0.28 µms
−1
ΩKD Rate of cPKC* deactivation 0.33 s
−1
KKC Ca
2+ affinity of PKC 0.5 µm
OK Rate of receptor phosphorylation 1.0 µm
−1s−1
21
A B
Figure 1. IP3 production. A Hydrolysis of the membrane lipid phosphatidylinositol 4,5-
bisphosphate (PIP2) by PLCβ and PLCδ isoenzymes produces IP3 and diacylglycerol (DAG).
The contribution of PLCβ to IP3 production depends on agonist binding to astrocyte G protein-
coupled receptors (GPCRs). This production pathway is inhibited via receptor phosphorylation
by Ca2+-dependent activation of conventional protein kinases C (cPKCs). Blue: promoting
pathway; red : inhibitory pathway.
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AB
Figure 2. IP3 and DAG degradation. A Degradation of IP3 occurs by phosphorylation into
inositol 1,3,4,5-tetrakisphosphate (IP4) by IP33K and dephosphorylation into lower inositol
phosphates by IP-5P. Both pathways are regulated by Ca2+: IP33K activity is stimulated by
phosphorylation by Ca2+/calmodulin-dependent protein kinase II (CaMKII), whereas IP-5P is
inhibited thereby. Moreover IP33K-mediated degradation could also be promoted by Ca
2+ and
DAG-dependent cPKC-mediated phosphorylation, while IP-5P could also be inhibited by IP4.
For the sake of simplicity, IP-5P dependence on Ca2+ and IP4 along with IP33K dependence
on cPKC are not taken into consideration in this study (dashed pathways). B DAG is mainly
degraded into phosphatidic acid (PA) by DAG kinases (DAGK) in a Ca2+-dependent fashion,
and to a minor extent, into 2-arachidonoylglycerol (2-AG) by DAG lipases (DAGL). In turn 2-
AG is hydrolized by monoacylglycerol lipase (MAGL) into arachidonic acid (AA). 2-AG and AA
may promote activity of DAGK and cPKC* (orange patwhays) although this scenario is not
taken into consideration here. Colors of other pathways as in Figure 1.
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Figure 3. G-ChI model. (left panel) Fit of IP3Rs kinetic parameters on experimental
data of steady-state open probabilities of type-2 IP3Rs by Ramos-Franco et al. (2000). In
this example, and through all this chapter, we consider the Li-Rinzel description for CICR.
This choice allows a reasonable fit (solid and dashed lines) of the receptors’ open probability
as function of either intracellular IP3 (N) or intracellular Ca
2+ ( ). The only exception is
for Ca2+ concentrations > 1 µm for which the open probability predicted by the Li-Rinzel
model (solid line) vanishes much more quickly than experimental values. (right panel) Sample
Ca2+ (C), IP3 (I) and h traces ensuing from a simulation of the G-ChI model to reproduce
experimental Ca2+ oscillations in cultured astrocytes (gray data points) triggered by application
of > 5 µm glutamate. Experimental data courtesy of Nitzan Herzog (University of Nottingham).
A saturating glutamate concentration (i.e. ΓA = 1) was assumed with initial conditions C(0) =
0.098 µm, h(0) = 0.972 and I(0) = 0.190 µm. Simulated Ca2+ and IP3 traces are reported
in normalized units with respect to minimum values of C0 = 0.1 µm and I0 = 0.16 µm and
peak values of Cˆ = 1.42 µm and Iˆ = 0.19 µm. Model parameters as in Table D1 except for
Oβ = 0.141 µms
−1 and O3K = 0.163 µms
−1.
24
Gl
u
(μ
M
)
0.0
0.1
0.2
0.3
As
t. 
Re
c.
Γ A
0.0
0.5
1.0
Ca
2+
, I
P 3
( 
.u
.)
C
I
0.0
0.1
0.2
IP
3 p
ro
d.
(μ
M
/s
)
Jβ
Jδ
0 2 4 6 8 10
Time (s)
0.0
0.1
0.2
IP
3 d
eg
r.
(μ
M
/s
)
J5P
J3K
Figure 4. Coexistence of different regimes of IP3 signaling. From top to bottom: (first
panel) Repetitive stimulation of an astrocyte by puffs of glutamate (8 µm, rectangular pulses
at rate 0.33Hz and 15% duty cycle); (second panel) fraction of activated astrocytic receptors;
(third panel) ensuing Ca2+ (C) and IP3 (I) traces (normalized with respect to their maximum
excursion: C0 = 40 nm, I0 = 50 nm, Cˆ = 0.73 µm, Iˆ = 0.15 µm); (fourth panel) total rate of
IP3 production (dashed line) and contributions to it by PLCβ (Jβ) and PLCδ (Jδ); (bottom
panel) total rate of IP3 degradation (dashed line) resulting from the combination of degradation
by IP-5P (J5P ) and IP33K (J3K). Besides Ca
2+ pulsed-oscillations, IP3 is mainly regulated by
PLCβ (orange trace) and IP-5P (violet trace), and its concentration tends to increase in an
integrative fashion with the number of glutamate puffs. During Ca2+ elevations instead, activity
of PLCδ (blue trace) and IP33K (red trace) become significant, with this latter responsible for a
sharp drop of intracellular IP3. Model parameters as in Table D1 except for CT = 10 µm, OP =
10 µms−1 and Oδ = 0.05 µms
−1.
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Figure 5. Threshold for CICR. A (top panel) Step increases of extracellular glutamate (color
coded) and resulting IP3 (central panel) and Ca
2+d˜ynamics (bottom panel) in a G-ChI astrocyte
model. Black marks at t = 0 denote stimulus onset. B (top panel) Latency for the onset of
CICR as a function of the applied glutamate concentration for the Ca2+ traces in A (black
dashed curve), as well as for 50% increases in the rate of PLCβ (Oβ), PLCδ (Oδ), IP33K (O3K)
and IP-5P (Ω5P ) respectively. Emergence of CICR was detected for
dC
dt ≥ 0.5 µm/s. (bottom
panel) Integral of IP3 concentration as a function of the latency values computed in the top
panel. This integral is a better estimator of CICR threshold than the sole IP3 concentration.
Model parameters as Figure 4.
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Figure 6. Regulation of Ca2+ oscillations by cPKC. A (top panel) Comparison between ex-
perimental traces for Ca2+ (black) and cPKC* (red) originally recorded in cultured astrocytes
by Codazzi et al. (2001) and simulations (bottom panel). Despite quantitive differences in the
shape and period of oscillations, the model can reproduce the essential correlation and phase
shift between Ca2+ and cPKC* dynamics observed in experiments. Ca2+ and cPKC* oscil-
lations were triggered assuming an extracellular glutamate concentration of 1.48 µm, and were
normalized according to their maximum excursion: C0 = 0.04 µm, P0 = 48 nm, Cˆ = 0.49 µm and
Pˆ = 65 nm. B DAG and cPKC* dynamics associated with two different rates of receptor phos-
phorylation by cPKC (OK , black traces) in response to a step increase of extracellular glutamate
(1.55 µm at t = 0). In the absence of receptor phosphorylation (gray traces), Ca2+ oscillations
would vanish due to saturating intracellular IP3 levels ensued from large receptor activation.
C Period of Ca2+ oscillations as a function of extracellular glutamate concentration. Receptor
phosphorylation by cPKC critically controls the oscillatory range (black and blue curves) with
respect to the scenario without cPKC activation (gray curve). Higher glutamate concentrations
are required to trigger oscillations for larger rates of DAG-dependent cPKC activation (OKD).
Parameters as in Table D1 except for ΩC = 6.207 s
−1, ΩL = 0.01 s
−1, Oβ = 1 µms
−1.
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